Carbetocin

This classification denotes an oxytocic and uterine stimulant with the molecular formula C45H69N11O12S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 88TWF8015Y, chemically known as 1-carboxytocin, 1-butanoic acid-2-(o-methyl-l-tyrosine)- but generally known as carbetocin, which bears US NIH Compound Identifier 71715. European Medicines Agency schedules Carbetocin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06125MIG. World Health Organization schedules carbetocin in its Anatomical Therapeutic Chemical (ATC) Classification. CARBETOCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule carbetocin under HS 29371900 and SITC 54154. As of Q4 2014, CARBETOCIN remains the US FDA Preferred Term for this commodity. Carbetocin bears US NLM identifiers UMLS ID C0054670 and NCI Concept Code C96858. SMILES: S1CC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N(C(=O)CCC1)C)CC1CCC(O)CC1)C(CC)C)CCC(=O)N)CC(=O)N)C(=O)N1C(CCC1)C(=O)NC(CC(C)C)C(=O)NCC(=O)N.